BRPI0808563B1 - Composição contendo extratos de cynara scolymus e de phaseolus vulgaris que são úteis no tratamento de obesidade - Google Patents

Composição contendo extratos de cynara scolymus e de phaseolus vulgaris que são úteis no tratamento de obesidade Download PDF

Info

Publication number
BRPI0808563B1
BRPI0808563B1 BRPI0808563-3A BRPI0808563A BRPI0808563B1 BR PI0808563 B1 BRPI0808563 B1 BR PI0808563B1 BR PI0808563 A BRPI0808563 A BR PI0808563A BR PI0808563 B1 BRPI0808563 B1 BR PI0808563B1
Authority
BR
Brazil
Prior art keywords
extract
cynara scolymus
phaseolus vulgaris
extracts
useful
Prior art date
Application number
BRPI0808563-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Ezio Bombardelli
Gabriele Fontana
Andrea Giori
Paolo Morazzoni
Cesare Ponzone
Massimo Ronchi
Original Assignee
Indena S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A filed Critical Indena S.P.A
Publication of BRPI0808563A2 publication Critical patent/BRPI0808563A2/pt
Publication of BRPI0808563B1 publication Critical patent/BRPI0808563B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BRPI0808563-3A 2007-03-07 2008-03-06 Composição contendo extratos de cynara scolymus e de phaseolus vulgaris que são úteis no tratamento de obesidade BRPI0808563B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US90532007P 2007-03-07 2007-03-07
EP07425132.3 2007-03-07
EP07425132A EP1967198B1 (en) 2007-03-07 2007-03-07 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
US60/905,320 2007-03-07
PCT/EP2008/001787 WO2008107184A1 (en) 2007-03-07 2008-03-06 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity

Publications (2)

Publication Number Publication Date
BRPI0808563A2 BRPI0808563A2 (pt) 2014-09-02
BRPI0808563B1 true BRPI0808563B1 (pt) 2018-02-14

Family

ID=38229761

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0808563-3A BRPI0808563B1 (pt) 2007-03-07 2008-03-06 Composição contendo extratos de cynara scolymus e de phaseolus vulgaris que são úteis no tratamento de obesidade

Country Status (19)

Country Link
US (2) US7887854B2 (enExample)
EP (1) EP1967198B1 (enExample)
JP (1) JP5355424B2 (enExample)
KR (1) KR101456555B1 (enExample)
CN (1) CN101641111B (enExample)
AT (1) ATE431155T1 (enExample)
AU (1) AU2008224057B2 (enExample)
BR (1) BRPI0808563B1 (enExample)
CA (1) CA2680078C (enExample)
DE (1) DE602007001128D1 (enExample)
DK (1) DK1967198T3 (enExample)
ES (1) ES2323815T3 (enExample)
IL (1) IL200709A (enExample)
NO (1) NO339322B1 (enExample)
PL (1) PL1967198T3 (enExample)
PT (1) PT1967198E (enExample)
RU (1) RU2453323C2 (enExample)
SI (1) SI1967198T1 (enExample)
WO (1) WO2008107184A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR101330190B1 (ko) 2011-09-20 2013-11-15 (주)그린솔루션스 하고초 추출물의 헴 옥시게나아제-1 발현 조절을 통한 지방 생성 억제용 화장료 조성물
KR102092977B1 (ko) 2011-12-19 2020-03-24 마리 케이 인코포레이티드 피부톤 향상을 위한 식물 추출물의 조합물
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
ITMI20121727A1 (it) * 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
ITMI20121749A1 (it) * 2012-10-16 2014-04-17 Indena Spa Estratti di helianthus annuus utili nel trattamento della sindrome metabolica e nella diminuzione dell'indice glicemico di alimenti e procedimento per la loro preparazione e composizioni che li contengono
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
DE202014005450U1 (de) * 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel
US20160302451A1 (en) * 2015-04-16 2016-10-20 Michael Hudnall Medical Food for Patients with Chronic Liver Disease
FR3075570B1 (fr) 2017-12-22 2020-01-03 Agro Innovation International Stimulation de la nitrification d'un sol avec des compositions comprenant un extrait de plante
IT201900000367A1 (it) * 2019-01-10 2020-07-10 Altergon Sa Composizioni comprendenti un peptide in grado di stimolare la via del segnale gprc6a-dipendente
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
ITMI20051347A1 (it) 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono

Also Published As

Publication number Publication date
KR101456555B1 (ko) 2014-10-31
ATE431155T1 (de) 2009-05-15
US7887855B2 (en) 2011-02-15
AU2008224057A1 (en) 2008-09-12
CA2680078C (en) 2016-12-06
US20100136145A1 (en) 2010-06-03
RU2009133338A (ru) 2011-03-10
SI1967198T1 (sl) 2009-08-31
CN101641111A (zh) 2010-02-03
CN101641111B (zh) 2012-05-23
US20080220097A1 (en) 2008-09-11
EP1967198B1 (en) 2009-05-13
AU2008224057B2 (en) 2012-07-19
NO20100527A1 (no) 2010-05-19
RU2453323C2 (ru) 2012-06-20
IL200709A0 (en) 2010-05-17
HK1121694A1 (en) 2009-04-30
CA2680078A1 (en) 2008-09-12
KR20090118051A (ko) 2009-11-17
PT1967198E (pt) 2009-06-15
DE602007001128D1 (de) 2009-06-25
JP2010520246A (ja) 2010-06-10
US7887854B2 (en) 2011-02-15
DK1967198T3 (da) 2009-08-10
IL200709A (en) 2013-07-31
JP5355424B2 (ja) 2013-11-27
PL1967198T3 (pl) 2009-10-30
WO2008107184A1 (en) 2008-09-12
ES2323815T3 (es) 2009-07-24
BRPI0808563A2 (pt) 2014-09-02
EP1967198A1 (en) 2008-09-10
NO339322B1 (no) 2016-11-28

Similar Documents

Publication Publication Date Title
BRPI0808563A2 (pt) Formulações contendo extratos de cynara scolymus e de phaseolus vulgaris que são úteis no tratamento de obesidade
Das et al. Okra and its various applications in drug delivery, food technology, health care and pharmacological aspects-a review
CN107206040A (zh) 用于管理或改进骨病症、软骨病症或二者的组合物和方法
WO2007119837A1 (ja) リパーゼ阻害剤
CN102212093B (zh) 黄酮苷类化合物及其制备方法和用途
BR112015005942B1 (pt) composição compreendendo extratos de cynara, coffea spp. e olea europaea, seu uso e composição farmacêutica
KR20070108940A (ko) 류마티스 관절염의 증상을 경감시키기 위한 영양 제품
JP6324391B2 (ja) 肥満を治療および予防するための製剤
WO2016130942A1 (en) Compositions providing extended energy and methods of use
EP1583547A1 (en) Anti-obesity ingretients from medicinal plants and their composittion
KR20190117153A (ko) 택란 추출물을 포함하는 골 질환 예방 또는 치료용 조성물
CN114727961A (zh) 包含天然产物提取物的具有改善的稳定性的药物组合物
WO2008107182A2 (en) Formulations of al pha-amylas e inhibitors of p. vulgaris with alpha-glucos idade inhibitores of s. oblonga or s. reticulata useful in the treatment of diabetes and obesity
WO2005074961A1 (ja) 体脂肪調整剤
KR100824704B1 (ko) 지실 추출물을 유효성분으로 함유하는 비만 치료 및 예방용조성물
CN105902601A (zh) 酸角壳提取物及其制备方法和降血脂中的应用
PL405318A1 (pl) Preparat złożony wspomagający odchudzanie na bazie wyciągów roślinnych
HK1121694B (en) Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
KR20190118270A (ko) 미선나무 추출물을 포함하는 간보호용 조성물
JP2024136690A (ja) 脂質蓄積抑制用経口組成物、肥満抑制用経口組成物及び抗炎症用経口組成物、並びに機能性食品、サプリメント及び医薬組成物
Alibekovna et al. Effect of Ferula foetida Extract on the Activity of Disaccharidases in the Small Intestine
HK1121696A (en) Formulations of alpha-amylase inhibitors of p. vulgaris with alpha-glucosidade inhibitores of s. oblonga or s. reticulata useful in the treatment of diabetes and obesity
KR20120117198A (ko) 프라티코사이드를 고순도로 함유한 길경 분획물을 유효성분으로 하는 항비만용 조성물

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2765 DE 02-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.